DD210053A5 - Verfahren zur herstellung von 7 beta-((z)-2-(2-aminothiazol-4-yl)-2-oximino-acetamido) -3-cephem-4-carbonsaeure-verbindungen und ihren salzen - Google Patents

Verfahren zur herstellung von 7 beta-((z)-2-(2-aminothiazol-4-yl)-2-oximino-acetamido) -3-cephem-4-carbonsaeure-verbindungen und ihren salzen Download PDF

Info

Publication number
DD210053A5
DD210053A5 DD83253755A DD25375583A DD210053A5 DD 210053 A5 DD210053 A5 DD 210053A5 DD 83253755 A DD83253755 A DD 83253755A DD 25375583 A DD25375583 A DD 25375583A DD 210053 A5 DD210053 A5 DD 210053A5
Authority
DD
German Democratic Republic
Prior art keywords
group
general formula
mixture
acid
compound
Prior art date
Application number
DD83253755A
Other languages
German (de)
English (en)
Inventor
Oine
Sugano
Yamada
Yamaguchi
Ohshima
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of DD210053A5 publication Critical patent/DD210053A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DD83253755A 1982-08-07 1983-08-05 Verfahren zur herstellung von 7 beta-((z)-2-(2-aminothiazol-4-yl)-2-oximino-acetamido) -3-cephem-4-carbonsaeure-verbindungen und ihren salzen DD210053A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8222823 1982-08-07

Publications (1)

Publication Number Publication Date
DD210053A5 true DD210053A5 (de) 1984-05-30

Family

ID=10532181

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83253755A DD210053A5 (de) 1982-08-07 1983-08-05 Verfahren zur herstellung von 7 beta-((z)-2-(2-aminothiazol-4-yl)-2-oximino-acetamido) -3-cephem-4-carbonsaeure-verbindungen und ihren salzen

Country Status (23)

Country Link
US (4) US4598075A (xx)
EP (2) EP0245619B1 (xx)
JP (3) JPS5951292A (xx)
KR (1) KR870001440B1 (xx)
AT (2) ATE35413T1 (xx)
AU (1) AU562248B2 (xx)
BG (3) BG42835A3 (xx)
CA (1) CA1231940A (xx)
CS (2) CS236798B2 (xx)
DD (1) DD210053A5 (xx)
DE (2) DE3377213D1 (xx)
DK (2) DK358983A (xx)
ES (3) ES524775A0 (xx)
FI (1) FI74972C (xx)
GR (1) GR78864B (xx)
IE (1) IE55406B1 (xx)
IL (1) IL69246A (xx)
NO (1) NO161068C (xx)
PH (1) PH18498A (xx)
PL (2) PL139932B1 (xx)
PT (1) PT77166B (xx)
SU (2) SU1227116A3 (xx)
ZA (1) ZA835411B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
JPS60132983A (ja) * 1983-12-21 1985-07-16 Tanabe Seiyaku Co Ltd チアゾ−ル酢酸誘導体及びその製法
JPS6178792A (ja) * 1984-09-26 1986-04-22 Yamanouchi Pharmaceut Co Ltd 7−〔α−(2−アミノ−4−チアゾリル)−α−(4−オキソ−2−アゼチジニル置換イミノ)アセトアミド〕−3−置換メチル−Δ↑3−セフエム−4−カルボン酸およびその製造法
JPS6185392A (ja) * 1984-10-03 1986-04-30 Tanabe Seiyaku Co Ltd セフアロスポリン化合物の新規製法
JPS61143379A (ja) * 1984-12-14 1986-07-01 Tanabe Seiyaku Co Ltd チアゾ−ル酢酸誘導体の製法
JPS61143380A (ja) * 1984-12-14 1986-07-01 Tanabe Seiyaku Co Ltd チアゾ−ル酢酸誘導体の製法
JPS61143381A (ja) * 1984-12-14 1986-07-01 Tanabe Seiyaku Co Ltd 光学活性チアゾ−ル酢酸誘導体の製法
CA1263399A (en) * 1984-12-19 1989-11-28 Hoffmann-La Roche Limited Process for the manufacture of aminothiazole acetic acid derivatives
JPS61171464A (ja) * 1985-01-23 1986-08-02 Dai Ichi Seiyaku Co Ltd オキシイミノ酪酸誘導体の製法
JPS63107989A (ja) * 1986-06-04 1988-05-12 Tanabe Seiyaku Co Ltd セファロスポリン化合物
IL82738A0 (en) * 1986-06-16 1987-12-20 Tanabe Seiyaku Co Cephalosporin compounds,their preparation and pharmaceutical compositions containing them
AT389701B (de) * 1987-10-08 1990-01-25 Tanabe Seiyaku Co Neue cephalosporinverbindungen und diese enthaltende pharmazeutische zusammensetzungen
JP4773154B2 (ja) * 2005-07-29 2011-09-14 小澤物産株式会社 レバー式カップリング

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
GB1536281A (en) * 1975-06-09 1978-12-20 Takeda Chemical Industries Ltd Cephem compounds
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
IE44888B1 (en) * 1976-03-09 1982-05-05 Fujisawa Pharmaceutical Co 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation theroef
DE2760484C2 (xx) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
FR2384782A1 (fr) * 1977-03-25 1978-10-20 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-acetoxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
SE448379B (sv) * 1978-03-31 1987-02-16 Roussel Uclaf O-substituerade oximderivat av 7-amino-tiazolyl-acetamidocefalosporansyra
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
DE2967356D1 (en) * 1978-07-17 1985-02-28 Fujisawa Pharmaceutical Co Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
US4284631A (en) * 1978-07-31 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them
GB2028305A (en) * 1978-08-03 1980-03-05 Hoechst Ag Cephem derivatives and processes for their manufacture
GB2061276B (en) * 1979-10-25 1983-05-25 Squibb & Sons Inc Imidazole and tetrazole derivatives of 7-((2-amino-4-thiazolyl)-oximino)cephalosporins
US4271157A (en) * 1980-02-28 1981-06-02 E. R. Squibb & Sons, Inc. Imidazole derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins
US4416879A (en) * 1980-09-08 1983-11-22 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
IL69246A (en) * 1982-08-07 1986-07-31 Tanabe Seiyaku Co 7-((2-aminothiazolyl-2-pyrrolidonyl or(piperidonyl)-oxyimino)acetamido)cephem carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
JPS59155391A (ja) * 1983-02-22 1984-09-04 Tanabe Seiyaku Co Ltd 新規セファロスポリン誘導体

Also Published As

Publication number Publication date
EP0101265A2 (en) 1984-02-22
US4598075A (en) 1986-07-01
US4742174A (en) 1988-05-03
DK361587A (da) 1987-07-10
CS236798B2 (en) 1985-05-15
EP0245619B1 (en) 1990-07-11
CS243484B2 (en) 1986-06-12
EP0101265B1 (en) 1988-06-29
ES8603496A1 (es) 1985-12-16
DE3381734D1 (de) 1990-08-16
PL139932B1 (en) 1987-03-31
FI74972B (fi) 1987-12-31
PT77166A (en) 1983-09-01
PT77166B (pt) 1986-01-28
SU1324586A3 (ru) 1987-07-15
ES531296A0 (es) 1985-08-01
IL69246A0 (en) 1983-11-30
ES8502121A1 (es) 1984-12-16
JPH0246588B2 (xx) 1990-10-16
AU1710483A (en) 1984-02-09
DK361587D0 (da) 1987-07-10
IE831648L (en) 1984-02-07
KR870001440B1 (ko) 1987-08-06
DK358983D0 (da) 1983-08-05
ES524775A0 (es) 1984-12-16
JPS5951292A (ja) 1984-03-24
IE55406B1 (en) 1990-09-12
NO161068B (no) 1989-03-20
IL69246A (en) 1986-07-31
GR78864B (xx) 1984-10-02
KR840005816A (ko) 1984-11-19
FI832770A (fi) 1984-02-08
US4598154A (en) 1986-07-01
SU1227116A3 (ru) 1986-04-23
JPS62294681A (ja) 1987-12-22
CS196483A2 (en) 1985-08-22
DE3377213D1 (en) 1988-08-04
ATE35413T1 (de) 1988-07-15
EP0101265A3 (en) 1985-04-10
PL243329A1 (en) 1985-02-13
JPS62294615A (ja) 1987-12-22
BG40967A3 (en) 1987-03-14
PH18498A (en) 1985-08-02
FI74972C (fi) 1988-04-11
CA1231940A (en) 1988-01-26
FI832770A0 (fi) 1983-08-02
NO161068C (no) 1989-06-28
ES535281A0 (es) 1985-12-16
DK358983A (da) 1984-02-08
PL140023B1 (en) 1987-03-31
JPH0360803B2 (xx) 1991-09-17
ATE54450T1 (de) 1990-07-15
NO832828L (no) 1984-02-08
ES8506707A1 (es) 1985-08-01
ZA835411B (en) 1984-03-28
EP0245619A1 (en) 1987-11-19
AU562248B2 (en) 1987-06-04
BG37838A3 (en) 1985-08-15
PL249964A1 (en) 1985-05-07
BG42835A3 (en) 1988-02-15
JPH0145473B2 (xx) 1989-10-03
US4727071A (en) 1988-02-23

Similar Documents

Publication Publication Date Title
DE3750443T2 (de) Cephalosporinverbindungen, Verfahren zu ihrer Herstellung und antibakterielle Mittel.
DE3311300C2 (xx)
CH652129A5 (de) Neue cephalosporine, verfahren zur herstellung derselben.
EP0034760A1 (de) Cephalosporinderivate, sie enthaltende pharmazeutische Präparate und Verfahren zu ihrer Herstellung
DE69618015T2 (de) Cephalosporinantibiotika
DD210053A5 (de) Verfahren zur herstellung von 7 beta-((z)-2-(2-aminothiazol-4-yl)-2-oximino-acetamido) -3-cephem-4-carbonsaeure-verbindungen und ihren salzen
CH617202A5 (xx)
EP0137441A2 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
DD249024A5 (de) Verfahren zur herstellung von cephalosporinverbindungen
DE2736471A1 (de) Ungesaettigte 7-acylamido-3-cephem- 4-carbonsaeure-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel und veterinaermittel
DE3247613A1 (de) Cephalosporinderivate und verfahren zu ihrer herstellung
DE3130404C2 (xx)
CH645116A5 (de) Cephem-verbindungen, verfahren zu ihrer herstellung und sie enthaltende antibakterielle pharmazeutische mittel.
DE3686749T2 (de) Cephalosporinverbindungen und sie enthaltende bakterizide.
DE2056983B2 (de) S-Heterocyclylthiomethyl-Cephalosporine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
EP0295630A2 (de) Cephalosporinderivate
CH626370A5 (en) Process for the preparation of the syn isomer or of a mixture of syn and anti isomers of 7beta-acylamidoceph-3-em-4-carboxylic acids with antibiotic activity
DE3041160C2 (xx)
DE2715038A1 (de) Neue antibakterielle verbindungen
JPH05508625A (ja) 新規なセファロスポリン化合物およびその製法
EP0035161B1 (de) Cephalosporine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH634848A5 (de) Verfahren zur herstellung neuer 7-(n-substituierter 2-phenylglycinamido)-3-substituierte-3-cephem-4-carbonsaeuren.
DE69033952T2 (de) Antibakterielle Cephalosporin-Derivate
DE2702552A1 (de) 7alpha-methoxy-cephalosporine und verfahren zur herstellung derselben
CH648035A5 (de) Cephalosporin-analoge, verfahren zu ihrer herstellung und sie enthaltendes arzneimittel.

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee